Johnson & Johnson (NYSE: JNJ): Think Like A Lender, Not An Investor

money audit

Johnson & Johnson (NYSE:JNJ) currently has a daily average trading volume of 7.52M but it saw 5368492 shares traded in last market. With a market cap of 367.43B USD, the company’s current market price of $152.67 came rising about 0.85 while comparing to the previous closing price of $151.38. In past 52 weeks, the stock remained buoying in the range of price level as high as $175.97 and as low as $143.13.

Taking a look at 20-day trading activity of Johnson & Johnson (JNJ) gives us an average price of $148.84, while its current price level is -13.24% below from 52-week high level whereas it is 6.67% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $152.52 while that of 200 days or SMA-200 reads an average of $157.07. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.01% during that period while stretching the period over a month that increases to 1.46%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 58.57 which implies that the stock is in neutral territory.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the HSBC Securities which upgraded the stock as “Buy” in its note to investors issued on April 18, 2024, recommending a price target of $170 for it. Wells Fargo downgraded its recommendation for the stock as a “Equal Weight” from “Overweight” on December 13, 2023 while assigning a price target range of $170-$163. UBS also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $167 and $180.

Over the week, JNJ’s stock price is moving 2.50% up while it is 5.69% when we observe its performance for the past one month. Year-to-date it is -2.60% down and over the past year, the stock is showing a downside performance of -4.31%.

The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 2.56 beaten by the consensus estimate of 2.62 for the same. In next quarter, company is expected to be making quarterly sales of $22.2B as analysts are expecting the sales for current fiscal year at $88.35B and seeing the company making $90.74B in sales next year. Moreover, analysts are in estimates of $22.28B for current-quarter revenue.

Currently, Johnson & Johnson’s total number of outstanding shares is 2.41B. Company’s return on investment (ROI) stands at 18.39% and return on equity (ROE) at 23.91%. It has a price to earnings ratio (P/E ratio) of 21.99 while having a 13.93 of forward P/E ratio. Stock’s beta reads 0.54. Stock has a price to book (P/B) ratio of 5.25 while price to sale or P/S ratio amounts to 4.10. Its return on asset (ROA) is 9.15% on average.